Insmed CCO J. Drayton Wise resigns effective immediately for medical reasons; stays as consultant
INSMED Inc
J. Drayton Wise resigned as Chief Commercial Officer effective April 16, 2025, for personal and medical reasons, unrelated to operations.
He will provide consulting services through December 31, 2025, with automatic two three-month extensions unless mutually terminated.
Consulting fee: $30,000/month during initial period; $20,000/month during extensions. Outstanding equity awards continue to vest.
No replacement named; Wise will support transition under a consulting agreement. Options exercisable for 3 months post-service or original 10-year expiry.
On April 16, 2025, J. Drayton Wise notified Insmed Incorporated (the “Company”) of his decision to resign from his position as the Company’s Chief Commercial Officer for personal and medical reasons, effective immediately.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
J. Drayton Wise resigned as Chief Commercial Officer at INSMED Inc.
Action
resigned
Role
Chief Commercial Officer
Exact text from the filing
On April 16, 2025, J. Drayton Wise notified Insmed Incorporated (the “Company”) of his decision to resign from his position as the Company’s Chief Commercial Officer for personal and medical reasons, effective immediately.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.